Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts
Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan
Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling
FASEB: Focus on Research Funding, Not PR
MD Anderson Researcher Charged With Placing Ethylene Glycol In Colleague’s Coffee
Trending Stories
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Karen Knudsen to leave ACS
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation